Literature DB >> 10738154

[Managed care in Latin America: transnationalization of the health sector in the context of reform].

C Iriart1, E E Merhy, H Waitzkin.   

Abstract

This article presents the results of the comparative research project "Managed Care in Latin America: Its Role in Health Reform". The project was conducted by teams in Argentina, Brazil, Chile, Ecuador, and the United States. The study's objective was to analyze the process by which managed care is exported, especially from the United States, and how managed care is adopted in Latin American countries. Our research methods included qualitative and quantitative techniques. Adoption of managed care reflects transnationalization of the health sector. Our findings demonstrate the entrance of large multinational financial capital into the private insurance and health services sectors and their intention of participating in the administration of government institutions and medical/social security funds. We conclude that this basic change involving the slow adoption of managed care is facilitated by ideological changes with discourses accepting the inexorable nature of public sector reform.

Mesh:

Year:  2000        PMID: 10738154     DOI: 10.1590/s0102-311x2000000100010

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  Health reform in Brazil: lessons to consider.

Authors:  Paulo Eduardo M Elias; Amelia Cohn
Journal:  Am J Public Health       Date:  2003-01       Impact factor: 9.308

2.  Multinational corporations and health care in the United States and Latin America: strategies, actions, and effects.

Authors:  Rebeca Jasso-Aguilar; Howard Waitzkin; Angela Landwehr
Journal:  J Health Soc Behav       Date:  2004

Review 3.  Chile's role in global health diplomacy: a narrative literature review.

Authors:  Jorge Ramírez; Leonel Valdivia; Elena Rivera; Marilia da Silva Santos; Dino Sepúlveda; Ronald Labonté; Arne Ruckert
Journal:  Global Health       Date:  2018-11-16       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.